Newsroom
Sorted by: Latest
-
Penguin Solutions Divests Remaining Interest in Brazil Memory Module Business
FREMONT, Calif.--(BUSINESS WIRE)--Penguin Solutions today announced the sale of its remaining 19% interest in Zilia Technologies Brazil for $46.08M per the Stock Transfer Agreement....
-
Fortune Media and Great Place To Work® Recognize World Wide Technology on 2026 ‘100 Best Companies to Work For’ List, Ranked No. 10
ST. LOUIS--(BUSINESS WIRE)--Great Place To Work® and Fortune media have recognized World Wide Technology (WWT) as one of the Fortune 100 Best Companies to Work For® in 2026. This is WWT’s 15th consecutive year being named to this prestigious list, this year coming in at 10th place. Earning a spot means that WWT is one of the best companies to work for in the country. “Celebrating 15 years as A Great Place To Work is a powerful reflection of the culture our teams have built together,” said Jim K...
-
NUBURU, Inc. – Letter to Shareholders
DENVER--(BUSINESS WIRE)--Dear Fellow Shareholders, With the filing of our 2025 Form 10-K, we want to clearly articulate what the financials reflect—and, importantly, what they do not yet capture. The 10-K captures NUBURU as it was for the financial year ended 31 December 2025. Since the financial year end, NUBURU has successfully executed its restructuring, refinancing and key strategic initiatives and investments. These have helped to ensure that NUBURU is well-positioned to continue to furthe...
-
Aldeyra Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ALDX
LOS ANGELES--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ALDX...
-
Vince Announces Reporting Date for Fourth Quarter and Fiscal Year 2025 Financial Results
NEW YORK--(BUSINESS WIRE)--Vince Holding Corp., (Nasdaq: VNCE) (“VNCE” or the “Company”), a global retail platform, today announced that it plans to report its fourth quarter and fiscal year 2025 financial results pre-market on Wednesday, April 15, 2026. The Company also plans to hold a conference call to discuss its financial results on the same day at 8:30 a.m. ET. During the conference call, the Company may answer questions concerning business and financial developments, trends and other bus...
-
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer
LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the first patient has been enrolled in the landmark global phase 3 BATTMAN (CO.33) trial (NCT07152821). This study is evaluating Agenus’ immunotherapy combination of botensilimab (BOT) plus balstilimab (BAL) versus best supportive care in patients with refractory, unresectable microsatellite stable (MSS)/mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC)...
-
Realbotix Provides AI Humanoid Robot Delivery Update
LAS VEGAS--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leading human-centric AI and humanoid robot manufacturer, announces the planned delivery of 19 robots and corresponding AI implementations for the months of March, April, and May of 2026. The company continues to develop its pipeline of orders as it moves to scale its production capacity and increase demand for its humanoids and AI. “Realbotix is solving one of the most i...
-
New Era Energy & Digital Partners with Stream Data Centers for Flagship TCDC Campus
MIDLAND, Texas--(BUSINESS WIRE)--New Era Energy & Digital, Inc. (Nasdaq: NUAI) (“New Era” or the “Company”), a developer and operator of next-generation digital infrastructure and integrated power assets in the Permian Basin, today announced that it has entered into a non-binding letter of intent (“LOI”) to form a joint venture for the development and financing of its Texas Critical Data Centers campus (“TCDC”) in West Texas. The joint venture will bring New Era together with Stream Data Ce...
-
Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced a global clinical trial collaboration with Amgen Inc. (NASDAQ: AMGN) to evaluate Zai Lab’s investigational delta-like ligand 3 (DLL3)-targeting antibody-drug conjugate (ADC), zocilurtatug pelitecan (zoci, formerly ZL-1310), in combination with Amgen’s IMDELLTRA® (tarlatamab-dlle), a DLL3-targeting Bispecific T-cell Engager (BiTE®) therapy in patients with extensive-stage small cell lung canc...
-
InTest Promotes Rich Rogoff to Chief Executive Officer
MT. LAUREL, N.J.--(BUSINESS WIRE)--InTest Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include Semiconductor, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, and Safety/Security, today announced that Rich Rogoff, Division President of InTest’s Environmental Technologies Division, has also been named President and Chief Executive Officer of InTest Corporation and ap...